Hemant Patel
Medical Oncology · Muscle Shoals, ALNPI 1528020096
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,164 of the $2,793 with a category attached, or 77.5%. It is spread thinly across 31 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,903 and has fallen 99.0% since, to $18 in 2023. That places this record below the midpoint for medical oncology clinicians in AL, where the typical reported total is $5,924.
Across 143 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tosoh Bioscience, Inc.$539
- Novartis$356
- AstraZeneca$250
- E.r. Squibb & Sons, L.L.C.$158
- Johnson & Johnson$148
- Pfizer$146
- plus $1K from 25 others
Across 10 payments — averaging $5867.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$32K
- Amgen$21K
- Pfizer$5K
What the payments were for
- Food & beverage$2,16477%
- Education$903%
- Gifts$53919%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tosoh Bioscience, Inc. | 1 | $539 |
| Novartis | 21 | $356 |
| AstraZeneca(2 entities) | 14 | $250 |
| E.r. Squibb & Sons, L.L.C. | 12 | $158 |
| Johnson & Johnson(2 entities) | 10 | $148 |
| Pfizer | 11 | $146 |
| Eisai Inc. | 8 | $109 |
| Merck | 7 | $107 |
| Amgen | 7 | $102 |
| Seagen Inc. | 6 | $98 |
| Daiichi Sankyo Inc. | 5 | $97 |
| Exelixis Inc. | 4 | $95 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $82 |
| Genentech USA, Inc. | 5 | $62 |
| Lilly USA, LLC | 4 | $60 |
| Boehringer Ingelheim | 3 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Incyte Corporation | 2 | $37 |
| Bristol Myers Squibb | 2 | $36 |
| Gilead | 2 | $29 |
| GSK | 1 | $24 |
| EMD Serono, Inc. | 2 | $23 |
| Array Biopharma Inc | 1 | $21 |
| Acceleron Pharma, Inc. | 1 | $20 |
| EUSA Pharma (US) LLC | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
| Clovis Oncology, Inc. | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Bayer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOL, AIA-PACK$539
How this compares
$2,793 in reported general payments places this provider in the 35th percentile of 30 medical oncology providers in Alabama.
Other medical oncology in Muscle Shoals
- Karl HaglerMuscle Shoals$3K
- Joelle HamiltonHomewood$361K
- Syed Abbas AliJasper$51K
- Pranitha ProdduturvarMobile$33K
- Johnny NacillaCullman$23K
- Michael GarciaJasper$23K
- John WaplesHuntsville$19K
- Susan BostickTuscaloosa$17K
- Brittany CaseDaphne$17K
- Charles LattuadaAnniston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.